Keith R. Leonard, President & CEO at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 13,000 shares at $43.56 ($584K) on 2015-05-01, disclosed to the SEC on 2015-05-04.
Scheduled sale ($584k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.56 | 2,768 | $121K | 20.6% |
| 2 | $44.26 | 1,100 | $49K | 8.3% |
| 3 | $45.35 | 8,532 | $387K | 66.3% |
| 4 | $46.41 | 600 | $28K | 4.8% |
| Total | $44.93 avg | 13,000 | $584K | 100% |
| Filing → |
| ISRG | SELL | 2020-02-13 | $927K | — | Filing → |
| SNNA | BUY | 2019-02-26 | $250K | — | Filing → |
| ISRG | SELL | 2017-09-01 | $854K | — | Filing → |